✦ LIBER ✦

The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Scribed by Mieke Kriege; Agnes Jager; Maartje J. Hooning; Elisabeth Huijskens; Jannet Blom; Carolien H. M. van Deurzen; Marijke Bontenbal; J. Margriet Collee; Marian B. E. Menke-Pluijmers; John W. M. Martens; Caroline Seynaeve

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 824 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphocyte radiosensitivity in BRCA1 and

Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility

✍ Julian Barwell; Laurent Pangon; Anne Georgiou; Ian Kesterton; Caroline Langman; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB 👁 1 views

## Abstract There is conflicting evidence as to whether individuals who are heterozygous for germ‐line __BRCA1__ or __BRCA2__ mutations have an altered phenotypic cellular response to irradiation. To investigate this, chromosome breakage and apoptotic response were measured after irradiation in per

Effect of pregnancy as a risk factor for

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

✍ Carey A. Cullinane; Jan Lubinski; Susan L. Neuhausen; Parviz Ghadirian; Henry T. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the

Breast cancer risk in BRCA1 and BRCA2 mu

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

✍ David J. Hughes; Sophie M. Ginolhac; Isabelle Coupier; Laure Barjhoux; Valérie G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB 👁 2 views

## Abstract Marked variation in phenotypic expression among __BRCA1__ and __BRCA2__ mutation carriers may be partly explained by modifier genes that influence mutation penetrance. Variation in CAG/CAA repeat lengths coding for stretches of glutamines in the C‐terminus of the AIB1 protein (amplified

Ovarian cancer susceptibility alleles an

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

✍ Susan J. Ramus; Antonis C. Antoniou; Karoline B. Kuchenbaecker; Penny Soucy; Jon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of

Frequency of BRCA1 and BRCA2 germline mu

Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

✍ Noriko Ikeda; Yasuo Miyoshi; Kohri Yoneda; Eiichi Shiba; Yoshizo Sekihara; Morit 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 2 views

Prevalence of BRCA1 and BRCA2 mutations

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

✍ Muhammad U. Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB 👁 2 views

## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his